Bayer faces a reduced payment obligation in the glyphosate lawsuit.

Operations are being reviewed and changed. - Bayer faces a reduced payment obligation in the glyphosate lawsuit.

Bayer, the pharmaceutical and agricultural chemicals firm, will pay less in a Roundup lawsuit concerning a glyphosate-containing weed killer.

The court in Philadelphia scaled down the damage award granted to the plaintiff by the jury from $2.25 billion to $400 million (€367.5 million), as stated in court papers. This was the highest damage award for the Roundup court cases that began in 2018. Bayer plans to lodge an appeal.

The company remarked, "Although the court has diminished the unconstitutionally excessive damage award, we do not concur with the court's ruling in the matter." The trial process contained severity errors that must be rectified, Bayer highlighted. The company added that it had effectively defended itself in 14 out of the last 20 cases. Moreover, Bayer noted that most of the legal actions had been settled.

The glyphosate-containing Roundup weed killer raised concerns for Bayer ever since the company procured the US firm Monsanto in 2018 for more than 60 billion euros. The first verdict against the DAX company surfaced in the same year. This triggered a series of legal cases in the US. In 2020, Bayer launched a $1 billion program to solve the majority of the legal disputes without accepting liability. However, potential risks still exist. As of the end of January, around 54,000 of the 165,000 cases were yet to be settled. The Roundup court cases have already led to €13 billion in expenses for Bayer. Provisions totaled $6.3 billion (€5.7 billion) at the end of 2023.

Read also:

1. Despite the reduced payment obligation in the glyphosate lawsuit, the legal dispute surrounding Bayer's acquisition of Monsanto and their Roundup weed killer continues to incur significant costs.
2. The pharmaceutical giant Bayer, based in Leverkusen, Germany, is engaged in a significant legal dispute over glyphosate in the USA, affecting their operations in the pharmaceuticals and agriculture sectors.
3. The legal case, which involves allegations against Bayer's weed killer containing glyphosate, is not only a concern for the company but also a challenge for the broader chemistry industry in Germany.
4. The legal battle over glyphosate in Philadelphia may also impact future legal processes and potentially influence how similar cases are handled globally, including in other countries such as the USA and Bayerr.
5. Legal experts in the USA are closely monitoring the Roundup court cases, as the outcome could have far-reaching implications for the use of glyphosate-based weed killers in agriculture and other industries worldwide.
6. The long-standing legal dispute between Bayer and the plaintiffs in the Roundup case could affect the company's reputation in the pharmaceuticals and agriculture sectors, potentially impacting their business growth in regions like the USA and Germany.
7. In the context of the ongoing legal dispute, Bayer has been proactive in engaging with various stakeholders, including consumers, regulatory bodies, and industry organizations, to promote transparency and address concerns regarding glyphosate and their Roundup product.

• Few cars weigh under a ton in present times.
• Lack of snow also opens up new opportunities for winter tourism
• Abrupt end to e-car subsidies
• The chemical industry has little confidence